Medicare Enrolled
Dr. John Lyzanchuk, DO
Family Medicine · Yakima, WA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lyzanchuk from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lyzanchuk?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lyzanchuk
Dr. John Lyzanchuk is a family medicine specialist in Yakima, WA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lyzanchuk performed 3,054 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lyzanchuk received a total of $10,865 from 42 pharmaceutical and/or device companies across 579 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lyzanchuk is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 2% volume in WA
$10,865 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,054
Medicare services
Top 2% in WA for family medicine
Not available
Unique patients (not deduplicated)
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,172 | $83 | $200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
397 | $59 | $150 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
217 | $128 | $275 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
152 | $10 | $45 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
122 | $1 | $13 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
103 | $31 | $35 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
101 | $76 | $80 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
99 | $123 | $250 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
88 | $42 | $90 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
80 | $8 | $41 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
68 | $4 | $25 |
| Home health agency supervision, complex multidisciplinary care Supervision by a physician or allowed practitioner for a patient receiving Medicare-covered services from a participating home health agency. This involves complex and multidisciplinary care modalities, with the patient not present during the supervision. |
59 | $81 | $150 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
58 | $9 | $75 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
45 | $164 | $329 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
39 | $8 | $20 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
30 | $1 | $30 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
28 | $0 | $31 |
| Inhalation treatment for airway obstruction or sputum production A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production. |
23 | $6 | $37 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
20 | $4 | $15 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
20 | $0 | $35 |
| X-ray of paranasal sinuses, 1-2 views An X-ray imaging test that produces 1 to 2 pictures of the paranasal sinuses to visualize the bone structures and air-filled spaces within the facial area. |
19 | $16 | $50 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
18 | $83 | $275 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
15 | $76 | $200 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
15 | $152 | $300 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
14 | $51 | $116 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
14 | $215 | $400 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
13 | $41 | $169 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
13 | $164 | $363 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
12 | $20 | $40 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$10,865
Total received (2018-2024)
Avg $1,552/year across 7 years
Top 2% in WA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
579
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,056
2023
$1,843
2022
$2,119
2021
$1,431
2020
$648
2019
$1,062
2018
$1,707
Payments by company (2024)
PFIZER INC.
$331
ABBVIE INC.
$272
AstraZeneca Pharmaceuticals LP
$215
Abbott Laboratories
$205
Boehringer Ingelheim Pharmaceuticals, Inc.
$174
Bayer Healthcare Pharmaceuticals Inc.
$174
Astellas Pharma US Inc
$161
Xeris Pharmaceuticals, Inc.
$89
Sumitomo Pharma America, Inc.
$83
GlaxoSmithKline, LLC.
$79
Amgen Inc.
$62
Daiichi Sankyo Inc.
$52
Novartis Pharmaceuticals Corporation
$51
Novo Nordisk Inc
$33
Kowa Pharmaceuticals America, Inc.
$28
Biogen, Inc.
$28
Exact Sciences Corporation
$18
Top 3 companies account for 39.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,733
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,211
PFIZER INC.
$945
GlaxoSmithKline, LLC.
$787
ABBVIE INC.
$688
Janssen Pharmaceuticals, Inc
$619
Abbott Laboratories
$615
Novo Nordisk Inc
$549
SANOFI-AVENTIS U.S. LLC
$505
Bayer Healthcare Pharmaceuticals Inc.
$411
Amgen Inc.
$393
Bayer HealthCare Pharmaceuticals Inc.
$291
Astellas Pharma US Inc
$268
Mylan Specialty L.P.
$190
Novartis Pharmaceuticals Corporation
$168
Lilly USA, LLC
$148
AbbVie Inc.
$148
Sumitomo Pharma America, Inc.
$142
Sunovion Pharmaceuticals Inc.
$127
E.R. Squibb & Sons, L.L.C.
$116
Xeris Pharmaceuticals, Inc.
$89
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$77
Daiichi Sankyo Inc.
$77
Kowa Pharmaceuticals America, Inc.
$72
US WorldMeds, LLC
$72
Esperion Therapeutics, Inc.
$64
Amarin Pharma Inc.
$47
Otsuka America Pharmaceutical, Inc.
$40
Harmony Biosciences LLC
$39
Biogen, Inc.
$28
Takeda Pharmaceuticals U.S.A., Inc.
$28
Teva Pharmaceuticals USA, Inc.
$26
SANOFI PASTEUR INC.
$19
Dexcom, Inc.
$19
Exact Sciences Corporation
$18
Hologic Sales and Service, LLC
$18
HARMONY BIOSCIENCES LLC
$15
Allergan Inc.
$14
Horizon Pharma plc
$14
Merck Sharp & Dohme Corporation
$13
Ironshore Pharmaceuticals Inc.
$12
Regeneron Healthcare Solutions, Inc.
$12
Top 3 companies account for 35.8% of all-time payments
Associated products mentioned in payments ›
AJOVY · ANORO · AREXVY · Aimovig · AirDuo Digihaler · Amitiza · BEXSERO · BREO · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · Cologuard Collection Kit · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GEMTESA · GVOKE HYPOPEN · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · Jornay PM 20mg capsules (Bottle of 100) · KRYSTEXXA · Kerendia · LEQEMBI · LEQVIO · LINZESS · LIVALO · LO LOESTRIN FE · LYRICA · Lucemyra/Lofexidine · MENQUADFI · MOUNJARO · MYRBETRIQ · NEXLETOL · NURTEC ODT · Otezla · Ozempic · PRADAXA · PRALUENT · Prolia · QULIPTA · REXULTI · RYBELSUS · Repatha · Rybelsus · SEGLENTIS · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Seglentis · THINPREP 2000 PROCESSOR · TOUJEO · TOVIAZ · TRELEGY ELLIPTA · TRULICITY · Tresiba · UBRELVY · VESICARE · VIBERZI · VRAYLAR · Vascepa · Veozah · Victoza · WAKIX · Wakix · Wegovy · XARELTO · XIFAXAN · YUPELRI · Yupelri · ZORYVE
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family medicine physicians in nearby ZIP areas
141
County median income
$68,015
Nearest hospital to ZIP centroid (approximate)
YAKIMA VALLEY MEMORIAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lyzanchuk is a clinical cardiology specialist, with above-average Medicare volume (top 2% in WA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lyzanchuk experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Lyzanchuk performed 1,172 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lyzanchuk receive payments from pharmaceutical companies?
Yes. Dr. Lyzanchuk received a total of $10,865 from 42 companies across 579 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lyzanchuk's costs compare to other family medicine physicians in Yakima?
Dr. Lyzanchuk's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lyzanchuk) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Yakima
Browse family medicine physicians in Yakima ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in WA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in WA
Which WA family medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology